Nabriva Therapeutics (NASDAQ:NBRV) Coverage Initiated at StockNews.com
Investment analysts at StockNews.com started coverage on shares of Nabriva Therapeutics (NASDAQ:NBRV – Get Free Report) in a note issued to investors on Wednesday. The firm set a “hold” rating on the biotechnology company’s stock. Nabriva Therapeutics Price Performance The company has a market cap of $45.46 million, a PE ratio of 0.00 and a […]
Investment analysts at StockNews.com started coverage on shares of Nabriva Therapeutics (NASDAQ:NBRV – Get Free Report) in a note issued to investors on Wednesday. The firm set a “hold” rating on the biotechnology company’s stock. Nabriva Therapeutics Price Performance The company has a market cap of $45.46 million, a PE ratio of 0.00 and a […]
